Bucana C - Search Results

1

Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.

Landen CN, Merritt WM, Mangala LS, Sanguino AM, Bucana C, Lu C, Lin YG, Han LY, Kamat AA, Schmandt R, Coleman RL, Gershenson DM, Lopez-Berestein G, Sood AK. Landen CN, et al. Among authors: bucana c. Cancer Biol Ther. 2006 Dec;5(12):1708-13. doi: 10.4161/cbt.5.12.3468. Epub 2006 Dec 30. Cancer Biol Ther. 2006. PMID: 17106249

2

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

Landen CN Jr, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G, Sood AK. Landen CN Jr, et al. Among authors: bucana c. Cancer Res. 2005 Aug 1;65(15):6910-8. doi: 10.1158/0008-5472.CAN-05-0530. Cancer Res. 2005. PMID: 16061675

3

Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines.

Apte SM, Bucana CD, Killion JJ, Gershenson DM, Fidler IJ. Apte SM, et al. Gynecol Oncol. 2004 Apr;93(1):78-86. doi: 10.1016/j.ygyno.2003.12.041. Gynecol Oncol. 2004. PMID: 15047217

4

Expression of metastasis-related genes in human epithelial ovarian tumors.

Herrera CA, Xu L, Bucana CD, Silva el VG, Hess KR, Gershenson DM, Fidler IJ. Herrera CA, et al. Int J Oncol. 2002 Jan;20(1):5-13. Int J Oncol. 2002. PMID: 11743636

5

Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.

Zhou RR, Jia SF, Zhou Z, Wang Y, Bucana CD, Kleinerman ES. Zhou RR, et al. Cancer Gene Ther. 2002 May;9(5):407-13. doi: 10.1038/sj.cgt.7700449. Cancer Gene Ther. 2002. PMID: 11961663

6

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.

Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM. Bruns CJ, et al. Among authors: bucana cd. Cancer. 2000 Aug 1;89(3):488-99. Cancer. 2000. PMID: 10931447

7

Pathogenesis and vascular integrity of breast cancer brain metastasis.

Lu W, Bucana CD, Schroit AJ. Lu W, et al. Among authors: bucana cd. Int J Cancer. 2007 Mar 1;120(5):1023-6. doi: 10.1002/ijc.22388. Int J Cancer. 2007. PMID: 17187362 Free article.

8

Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade.

Yigitbasi OG, Younes MN, Doan D, Jasser SA, Schiff BA, Bucana CD, Bekele BN, Fidler IJ, Myers JN. Yigitbasi OG, et al. Cancer Res. 2004 Nov 1;64(21):7977-84. doi: 10.1158/0008-5472.CAN-04-1477. Cancer Res. 2004. PMID: 15520205

9

Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.

Kitadai Y, Sasaki T, Kuwai T, Nakamura T, Bucana CD, Hamilton SR, Fidler IJ. Kitadai Y, et al. Int J Cancer. 2006 Dec 1;119(11):2567-74. doi: 10.1002/ijc.22229. Int J Cancer. 2006. PMID: 16988946 Free article.

10

Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8.

Huang S, Robinson JB, Deguzman A, Bucana CD, Fidler IJ. Huang S, et al. Among authors: bucana cd. Cancer Res. 2000 Oct 1;60(19):5334-9. Cancer Res. 2000. PMID: 11034066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page